Insider Transactions in Q2 2023 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,138
+50.0%
|
-
|
|
Jun 30
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+12.97%
|
-
|
|
Jun 30
2023
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
738
+1.84%
|
-
|
|
Jun 30
2023
|
Christina Teng Topsoe |
BUY
Open market or private purchase
|
Indirect |
3,000
+23.44%
|
$27,000
$9.32 P/Share
|
|
Jun 30
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,108
+0.11%
|
-
|
|
Jun 30
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.02%
|
-
|
|
Jun 30
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+13.56%
|
-
|
|
Jun 30
2023
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.6%
|
-
|
|
Jun 30
2023
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
3,500
+4.11%
|
$31,500
$9.25 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
54,740
+1.81%
|
$492,660
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
54,740
-1.84%
|
$492,660
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
80,423
+2.63%
|
$723,807
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
SELL
Open market or private sale
|
Indirect |
80,423
-2.7%
|
$723,807
$9.42 P/Share
|
|
Jun 29
2023
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
3,500
+4.29%
|
$31,500
$9.1 P/Share
|
|
Jun 26
2023
|
M Kathleen Behrens |
BUY
Open market or private purchase
|
Indirect |
112,500
+25.38%
|
$900,000
$8.0 P/Share
|
|
May 23
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.12%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.48%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,259
-1.49%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
982
-0.35%
|
$11,784
$12.66 P/Share
|
|
May 23
2023
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,259
-0.51%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.21%
|
$15,108
$12.66 P/Share
|
|
May 15
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
962
+1.69%
|
$10,582
$11.71 P/Share
|
|
May 15
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
961
+2.21%
|
$10,571
$11.71 P/Share
|
|
May 15
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
960
+0.69%
|
$10,560
$11.71 P/Share
|
|
May 15
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
960
+0.77%
|
$10,560
$11.71 P/Share
|
|
May 15
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
398
+0.76%
|
$4,378
$11.71 P/Share
|
|
Apr 18
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
34,200
+21.89%
|
-
|
|
Apr 18
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,497
+17.0%
|
-
|
|
Apr 18
2023
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+16.49%
|
-
|
|
Apr 18
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,126
+13.27%
|
-
|
|
Apr 05
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
935
-2.69%
|
$11,220
$12.6 P/Share
|
|
Apr 04
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+33.73%
|
-
|
|
Apr 04
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+32.29%
|
-
|
|
Apr 04
2023
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+50.0%
|
-
|
|
Apr 04
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+18.33%
|
-
|
|
Apr 04
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+43.45%
|
-
|
|
Apr 04
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+33.01%
|
-
|
|
Apr 04
2023
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+31.82%
|
-
|